JY
INBX icon

Jeff Yass’s Inhibrx INBX Stock Holding History

Jeff Yass’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Buy
72,200
+19,400
+37% +$1.94M ﹤0.01% 4042
2026
Q1 		$3.55M Sell
52,800
-72,300
-58% -$5.36M ﹤0.01% 4912
2025
Q4 		$9.88M Buy
125,100
+104,500
+507% +$7.12M ﹤0.01% 3056
2025
Q3 		$694K Buy
+20,600
New +$507K ﹤0.01% 8216
2025
Q2 		– Sell
-35,500
Closed -$497K – 13165
2025
Q1 		$497K Buy
35,500
+16,300
+85% +$221K ﹤0.01% 8920
2024
Q4 		$296K Sell
19,200
-16,600
-46% -$253K ﹤0.01% 9862
2024
Q3 		$561K Buy
35,800
+18,000
+101% +$253K ﹤0.01% 8191
2024
Q2 		$252K Buy
+17,800
New +$278K ﹤0.01% 9838

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's INBX Position: Q2 2026 in Review

Jeff Yass reduced its Inhibrx (INBX) stake by 82% in Q2 2026, selling an estimated $8.08M and leaving 17,272 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #6954.

Jeff Yass first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $23.5M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Jeff Yass held 17,272 shares of Inhibrx worth $1.64M as of Q2 2026.
  • Jeff Yass sold 80,601 Inhibrx shares in Q2 2026, an estimated $8.08M.
  • Inhibrx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6954 holding.
  • Jeff Yass first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Jeff Yass's Inhibrx position peaked at $23.5M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.